Now showing items 1-1 of 1
Genetically modified mesenchymal stem cells overexpressing CCR2 for cell therapy in critical limb ischemia
Critical Limb Ischemia (CLI) is an advanced stage of Peripheral Arterial Disease (PAD) and a global health problem. Patients with CLI may present with rest pain, gangrene and/or ulceration of the lower limb. Effective ...